BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2023 4:48:37 PM | Browse: 142 | Download: 572
Publication Name World Journal of Clinical Cases
Manuscript ID 84849
Country China
Received
2023-03-30 08:20
Peer-Review Started
2023-03-30 08:23
To Make the First Decision
Return for Revision
2023-07-03 07:58
Revised
2023-07-08 17:43
Second Decision
2023-07-21 02:49
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2023-07-21 07:32
Articles in Press
2023-07-21 07:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
2023-08-22 16:15
Typeset the Manuscript
2023-09-11 02:00
Publish the Manuscript Online
2023-09-20 16:48
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Tumor recurrence after pathological complete response in locally advanced gastric cancer after neoadjuvant therapy: Two case reports
Manuscript Source Unsolicited Manuscript
All Author List Yu Xing, Zi-Li Zhang, Zhi-Ying Ding, Wei-Liang Song and Tong Li
ORCID
Author(s) ORCID Number
Yu Xing http://orcid.org/0000-0001-8075-9612
Zi-Li Zhang http://orcid.org/0009-0006-3189-5160
Zhi-Ying Ding http://orcid.org/0009-0005-8649-3778
Wei-Liang Song http://orcid.org/0000-0002-8912-7897
Tong Li http://orcid.org/0000-0002-1748-6030
Funding Agency and Grant Number
Funding Agency Grant Number
Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-035A
Tianjin Science and Technology Project 21JCYBJC01590
Corresponding Author Tong Li, MD, PhD, Professor, Department of Surgery, The Third Central Clinical College of Tianjin Medical University, No. 83 Jintang Road, Hedong District, Tianjin 300170, China. litong3zx@sina.com
Key Words Programmed death protein 1; SOX; Pathological complete response; Microsatellite Instability High; Mismatch repair function defect; Case report
Core Tip Due to the synergistic effect of chemotherapy and immunotherapy, the enhanced anti-tumor effect has achieved commendable remission rate and survival benefit. We reported two patients who achieved pathological complete remission (ypCR) with programmed death protein 1 inhibitor combined with SOX (S-1+ oxaliplatin) perioperative treatment. Surprisingly, two patients underwent clinical observation after surgery but developed different degrees of metastasis at about six months after surgery. Moreover, achieving a ypCR reflects a superb short-term treatment response but does not necessarily predict long-term survival.
Publish Date 2023-09-20 16:48
Citation Xing Y, Zhang ZL, Ding ZY, Song WL, Li T. Tumor recurrence after pathological complete response in locally advanced gastric cancer after neoadjuvant therapy: Two case reports. World J Clin Cases 2023; 11(27): 6483-6490
URL https://www.wjgnet.com/2307-8960/full/v11/i27/6483.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i27.6483
Full Article (PDF) WJCC-11-6483-with-cover.pdf
Full Article (Word) WJCC-11-6483.docx
CARE Checklist–2016 84849-CARE-Checklist–2016-revision.pdf
Manuscript File 84849_Auto_Edited-LJH-JLW_Kerr C_Clear Copy.docx
Answering Reviewers 84849-Answering reviewers.pdf
Audio Core Tip 84849-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 84849-Conflict-of-interest statement.pdf
Copyright License Agreement 84849-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 84849-Grant application form(s).pdf
Signed Consent for Treatment Form(s) or Document(s) 84849-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 84849-Language certificate.pdf
Peer-review Report 84849-Peer-review(s).pdf
Scientific Misconduct Check 84849-Bing-Liu JH-2.png
Scientific Misconduct Check 84849-CrossCheck.png
Scientific Editor Work List 84849-Scientific editor work list.pdf
CrossCheck Report 84849-CrossCheck report.pdf